Invion (Australia) Profile

AUD 0.002  5.13%

Invion Summary

Invion Limited (IVX) is traded on Australian Securities Exchange in Australia. It is located in 722 High Street and employs 1 people. The company currently falls under 'Small-Cap' category with current market capitalization of 214.2 M. Invion Limited has 5.49 B outstanding shares. INVION FPO has accumulated about 281.51 K in cash with (799.93 K) of positive cash flow from operations.
Check Invion Probability Of Bankruptcy

Key Fundamentals

Invion Against Markets

Current Ratings

Invion 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Invion Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Invion Limited, a clinical-stage drug development company, develops treatments for inflammatory diseases in Australia and the United States. It has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers. Invion operates under Drug Manufacturers - Specialty Generic classification in Australia and traded on Australian Securities Exchange. It employs 1 people. more
NameInvion Limited
CEO, Managing DirectorGregory CollierView All
Macroaxis Advice
InstrumentAustralia Stock View All
Business Address722 High Street
ExchangeAustralian Securities Exchange
Phone61 3 9081 6005
CurrencyAUD - Australian Dollar
Please also check Risk vs Return Analysis. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.